Chunhua Xi Selected Research

Hypoxia (Hypoxemia)

1/2017	Vasohibin 2 promotes epithelial-mesenchymal transition in human breast cancer via activation of transforming growth factor β 1 and hypoxia dependent repression of GATA-binding factor 3.
1/2017	Hypoxia Induces Internalization of κ-Opioid Receptor.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Chunhua Xi Research Topics

Disease

7	Neoplasms (Cancer) 03/2023 - 12/2016
4	Pancreatic Neoplasms (Pancreatic Cancer) 05/2021 - 01/2017
3	Breast Neoplasms (Breast Cancer) 03/2019 - 12/2016
2	Hemorrhage 02/2024 - 03/2023
2	Sleep Initiation and Maintenance Disorders (Insomnia) 12/2023 - 01/2021
2	Diabetic Retinopathy (Retinopathy, Diabetic) 01/2022 - 01/2018
2	Inflammation (Inflammations) 04/2021 - 12/2016
2	Hypoxia (Hypoxemia) 01/2017 - 01/2017
1	Peptic Ulcer (Peptic Ulcers) 02/2024
1	Cognitive Dysfunction 11/2023
1	Alzheimer Disease (Alzheimer's Disease) 11/2023
1	Neoplasm Metastasis (Metastasis) 03/2023
1	Pancreatic Fistula (Pancreatic Fistulas) 03/2023
1	Apnea 01/2023
1	Autistic Disorder (Autism) 01/2023
1	Hypertension (High Blood Pressure) 01/2022
1	Coronary Artery Disease (Coronary Atherosclerosis) 01/2022
1	Cerebrovascular Disorders (Cerebrovascular Occlusion) 01/2022
1	Renal Insufficiency (Renal Failure) 01/2022
1	Necrosis 04/2021
1	Pathologic Processes 04/2021
1	Adenocarcinoma 10/2019
1	Hypoglycemia (Reactive Hypoglycemia) 01/2018
1	Pleural Effusion (Pleural Effusions) 12/2017
1	Ischemia 01/2017
1	Neuroblastoma 01/2017
1	Brain Hypoxia-Ischemia (Hypoxia Ischemia, Brain) 01/2017
1	Neurologic Manifestations (Neurological Manifestations) 12/2016
1	Brain Ischemia (Cerebral Ischemia) 12/2016
1	Infarction (Infarctions) 12/2016
1	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 12/2016

Drug/Important Bio-Agent (IBA)

4	Proteins (Proteins, Gene)FDA Link 04/2021 - 12/2016
2	Glucose (Dextrose)FDA LinkGeneric 01/2023 - 01/2017
2	Oxygen (Dioxygen)IBA 01/2023 - 01/2017
2	EnzymesIBA 04/2021 - 12/2016
2	ImmunosorbentsIBA 04/2021 - 12/2016
2	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 03/2019 - 12/2016
2	Phenobarbital (Luminal)FDA Link 03/2019 - 12/2016
2	Angiogenesis Inducing Agents (Angiogenesis Factor)IBA 01/2017 - 12/2016
2	Opioid Receptors (Opioid Receptor)IBA 01/2017 - 12/2016
1	AntacidsIBA 02/2024
1	Dopamine (Intropin)FDA LinkGeneric 12/2023
1	Biomarkers (Surrogate Marker)IBA 11/2023
1	Amyloid beta-PeptidesIBA 11/2023
1	Carbon DioxideIBA 01/2023
1	InterleukinsIBA 04/2021
1	Interleukin-6 (Interleukin 6)IBA 04/2021
1	9- (benzoyloxy)- 2- (3- furanyl)dodecahydro- 6a,10b- dimethyl- 4,10- dioxo- 2H- naphtho(2,1- c)pyran- 7- carboxylic acid methyl esterIBA 04/2021
1	NLR ProteinsIBA 04/2021
1	Norepinephrine (Noradrenaline)FDA LinkGeneric 01/2021
1	Messenger RNA (mRNA)IBA 01/2021
1	RNA (Ribonucleic Acid)IBA 01/2021
1	Small Cytoplasmic RNAIBA 01/2021
1	Carbonic Anhydrase IXIBA 01/2021
1	abemaciclibIBA 10/2019
1	Cyclin-Dependent Kinase Inhibitor p16IBA 10/2019
1	Tumor Suppressor Protein p14ARF (p14ARF)IBA 10/2019
1	Blood Glucose (Blood Sugar)IBA 01/2018
1	Amylases FDA Link 12/2017
1	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2017
1	tdTomatoIBA 01/2017
1	Gemcitabine FDA Link 01/2017
1	Narcotic Antagonists (Opioid Antagonists)IBA 01/2017
1	Dopamine Receptors (Dopamine Receptor)IBA 01/2017
1	Ribonucleotide Reductases (Ribonucleotide Reductase)IBA 01/2017
1	Transcription Factors (Transcription Factor)IBA 01/2017
1	Cadherins (E-Cadherin)IBA 01/2017
1	Potassium Channel Blockers (Blockers, Potassium Channel)IBA 01/2017
1	Dynamins (Dynamin)IBA 01/2017
1	Conditioned Culture MediaIBA 12/2016
1	Caspase 3 (Caspase-3)IBA 12/2016
1	salvinorin AIBA 12/2016
1	Evans Blue (Blue, Evans)FDA Link 12/2016
1	Interleukin-10 (Interleukin 10)IBA 12/2016
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 12/2016

Therapy/Procedure

2	Pancreatectomy 03/2023 - 05/2021
1	Pancreaticoduodenectomy 02/2024
1	Length of Stay 03/2023
1	Blood Transfusion (Blood Transfusions) 03/2023
1	Vitrectomy 01/2022
1	Conduction Anesthesia (Regional Anesthesia) 01/2022
1	Therapeutics 01/2021
1	Perioperative Period 01/2018
1	General Anesthesia 01/2018